<?xml version="1.0" encoding="UTF-8"?>
<ref id="b38-1040138">
 <label>38.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rummel</surname>
    <given-names>MJ</given-names>
   </name>
   <name>
    <surname>Knauf</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Goener</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Two years rituximab maintenance vs. observation after first line treatment with bendamustine plus rituximab (B-R) in patients with mantle cell lymphoma: first results of a prospective, randomized, multi-center phase II study (a subgroup study of the StiL NHL7-2008 MAINTAIN trial)</article-title>. 
  <source>J Clin Oncol</source>. 
  <year>2016</year>;
  <volume>34</volume>(
  <issue>15_suppl</issue>):
  <fpage>7503</fpage>.
 </mixed-citation>
</ref>
